Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-04-003399
Filing Date
2004-03-12
Accepted
2004-03-12 16:19:42
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d13063e10vk.htm 10-K 718678
3 FIRST AMENDMENT TO RIGHTS AGREEMENT d13063exv4w3.txt EX-4.3 15865
4 1995 STOCK OPTION PLAN d13063exv10w4.txt EX-10.4 38430
5 2000 EMPLOYEE STOCK COMPENSATION PLAN d13063exv10w7.txt EX-10.7 54196
6 CONSULTING SERVICES AGREEMENT d13063exv10w18.txt EX-10.18 28511
7 COMPUTATION OF EARNINGS PER SHARE d13063exv11w1.txt EX-11.1 2970
8 CODE OF ETHICS FOR SENIOR FINANCIAL OFFICERS d13063exv14w1.txt EX-14.1 7053
9 CONSENT OF ERNST & YOUNG LLP d13063exv23w1.htm EX-23.1 1344
10 CERTIFICATION OF PRESIDENT AND CEO - SECTION 302 d13063exv31w1.txt EX-31.1 3132
11 CERTIFICATION OF SENIOR VP AND CFO - SECTION 302 d13063exv31w2.txt EX-31.2 3141
12 CERTIFICATION PURSUANT TO SECTION 906 d13063exv32w1.txt EX-32.1 1372
13 CERTIFICATION PURSUANT TO SECTION 906 d13063exv32w2.txt EX-32.2 1411
  Complete submission text file 0000950134-04-003399.txt   879162
Mailing Address 4545 HORIZON HILL BLVD SAN ANTONIO TX 78229
Business Address 4545 HORIZON HILL BLVD SAN ANTONIO TX 78229 210-949-8200
ILEX ONCOLOGY INC (Filer) CIK: 0001001915 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22147 | Film No.: 04666364
SIC: 2836 Biological Products, (No Diagnostic Substances)